This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Intuitive Surgical Plunges After Results Fail Expectations

NEW YORK (TheStreet) -- Shares of Intuitive Surgical (ISRG ) plummeted more than 16% during Tuesday trading after it said its second-quarter earnings will show a dramatic decrease in growth.

In its preliminary second-quarter results, released late on Monday, the surgical robotics specialist said it expects revenue to increase 7% year-over-year to $537 million. This growth rate, however, will be down dramatically from 23% in the prior quarter.

The results pushed Intuitive's shares southward in Tuesday trading, ending the session down 16.15% at $419.30.

Wall Street was clearly unimpressed with the company's second-quarter revenue number. Analysts with JMP Securities had expected sales revenue to be between $623 million and $629 million.

Intuitive's report will be the worst since the third quarter of 2009, according to Canaccord Genuity. "Intuitive Surgical had reported system sales growth greater than 15% for 9 consecutive quarters" wrote Canaccord analysts.

A slowdown in sales of Intuitive's Da Vinci system weighed on the company's second-quarter numbers. The Sunnyvale, Calif.-based firm expects its Da Vinci revenue to decrease 6% to $215 million compared to the prior year's quarter.

Intuitive sold a total of 143 Da Vinci systems during the second quarter, including 90 in the U.S., down from 150 and 124, respectively, in the same period last year.

In a statement, the company blamed the U.S. decline on a number of factors. These include increased economic pressure on hospitals, which caused some customers to defer their purchases, and a slowdown in medical procedures.

"Healthcare reform uncertainty and weak procedure volumes are placing increased pressure on purchasing, elongating decision timelines, and driving year over year declines in equipment provider revenue," Goldman Sachs analysts wrote in a report released on Tuesday.

Goldman Sachs believe that procedures were delayed as surgeons waited for the newest models of the Endowrist Monopolar Curved Scissors that are more resistant to microcracking.

Canaccord, JMP Securities and Goldman Sachs downgraded the equity due to the quarterly report. JMP analysts lowered their 2013 expectations to $2.4 billion from $2.6 billion. The consensus is predicting $2.58 billion for this year. Price targets range from $440 and $500.

-- Written by Robert Arenella in New York

>To contact the writer of this article, click here: Robert Arenella.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs